Targeting the fusion process of SARS-CoV-2 infection by small molecule inhibitors

Authors

Seung Bum Park, NIDDK, NIH, Bethesda
Parker Irvin, NIDDK, NIH, Bethesda
Zongyi Hu, NIDDK, NIH, Bethesda
Mohsin Khan, NIDDK, NIH, Bethesda
Xin Hu, NCATS, NIH, Rockville
Qiru Zeng, Washington University School of Medicine in St. Louis
Catherine Chen, NCATS, NIH, Rockville
Miao Xu, NCATS, NIH, Rockville
Madeleine Leek, NIDDK, NIH, Bethesda
Ruochen Zang, Washington University School of Medicine in St. Louis
James Brett Case, Washington University School of Medicine in St. Louis
Wei Zheng, NCATS, NIH, Rockville
Siyuan Ding, Washington University School of Medicine in St. Louis
T. Jake Liang, NIDDK, NIH, Bethesda

Journal

mBio

Publication Date

1-11-2022

Volume

13

Issue

1

First Page

e0323821

Document Type

Open Access Publication

DOI

10.1128/MBIO.03238-21

Rights and Permissions

Park SB, Irvin P, Hu Z, Khan M, Hu X, Zeng Q, Chen C, Xu M, Leek M, Zang R, Case JB, Zheng W, Ding S, Liang TJ. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio. 2022 Jan 11;13(1):e0323821. doi.org/10.1128/MBIO.03238-21 This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Recommended Citation

Park, Seung Bum; Irvin, Parker; Hu, Zongyi; Khan, Mohsin; Hu, Xin; Zeng, Qiru; Chen, Catherine; Xu, Miao; Leek, Madeleine; Zang, Ruochen; Case, James Brett; Zheng, Wei; Ding, Siyuan; and Liang, T. Jake, "Targeting the fusion process of SARS-CoV-2 infection by small molecule inhibitors." mBio. 13, 1. e0323821 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11883